About Creavo

About
Creavo

A vision to transform cardiology

We believe our technology has the power to transform the way that heart disease is identified and subsequently treated. Through our ground breaking MCG technology, we aim to reduce the economic burden on healthcare systems worldwide.

A vision to transform cardiology

We believe our technology has the power to transform the way that heart disease is identified and subsequently treated. Through our ground breaking MCG technology, we aim to reduce the economic burden on healthcare systems worldwide.

Timeline of Key Achievements

April 2014

Company created as a spin out from the University of Leeds with initial £1.6m “seed funding”

February 2015

60 60 clinical study completed at Leeds

July 2015

£4.6m raised in Series A funding round

February 2016

Company received ISO 13485

August 2016

Became Creavo Medical Technologies

November 2016

Creavo's research device receives CE mark

January 2017

Start of 750 patient, multi-site effectiveness study in five major UK ED's

May 2017

£13.4m raised in Series B funding round

Oct 2017

Creavo's research device receives FDA 510(k) approval

July 2018

Start of 720 patient, multi-site effectiveness study in five major US healthcare research facilities

Meet the board

Robert Barr

Robert Barr

Chairman of the Board

Steve Parker

Steve Parker

Chief Executive Officer

John von Benecke

John von Benecke

Chief Financial Officer

Prof Ben Varcoe

Prof Ben Varcoe

Chief Scientific Officer

Chris Meredith

Chris Meredith

Non Executive Director

Simon Graindorge

Simon Graindorge

Non Executive Director

Pierre Chauvineau

Pierre Chauvineau

Non Executive Director

Dr Sarah Jarmin

Dr Sarah Jarmin

Board Member

Meet the medical advisory board

Dr Richard Charles

Dr Richard Charles

Chair Medical Advisory Board

Prof John Camm

Prof John Camm

Board Member

Dr Robert Henderson

Dr Robert Henderson

Board Member

Prof Rod Stables

Prof Rod Stables

Board Member

Dr Francis Morris

Dr Francis Morris

Board Member

Dr Faizel Osman

Dr Faizel Osman

Board Member

Meet the executive team

Steve Parker

Steve Parker

Chief Executive Officer

John von Benecke

John von Benecke

Chief Financial Officer

Bob Roopra

Bob Roopra

Director of Business Development

Andrew Mullen

Andrew Mullen

Director of Operations

Lynda Unitt

Lynda Unitt

Clinical Research Manager

Prof Ben Varcoe

Prof Ben Varcoe

Chief Scientific Officer

Awards

Send us your enquiry

To find out more about Creavo, our ongoing clinical work or our international commercial collaborations please complete the following form:

Commercial and Development Office

Creavo Medical Technologies Limited
2020 House, Siskin Drive
Middlemarch Business Park
Coventry
CV3 4FJ

Registered Address

Creavo Medical Technologies Limited
Leeds Innovation Centre
103 Clarendon Road
Leeds,
LS2 9DF

Registered Address

Creavo Medical Technologies Limited
Leeds Innovation Centre
103 Clarendon Road
Leeds,
LS2 9DF

US office

Creavo Medical Technologies Inc
155 Seaport Boulevard
Boston
MA02210

US office

Creavo Medical Technologies Inc
155 Seaport Boulevard
Boston
MA02210